Medifast, Inc. (MED) 追踪市盈率为负值 -6.0, 表示公司目前在过去十二个月 (TTM) 基础上处于亏损状态。 追踪盈利收益率为 -16.74%.
本页证实的标准:
SharesGrow 综合评分： 51/100 其中 2/7 项标准通过。
| Year | P/E (TTM) | PEG 比率 | P/B 比率 | P/S 比率 | 股息收益率 |
|---|---|---|---|---|---|
| 2016 | 27.6 | -2.73 | 5.13 | 1.80 | 2.41% |
| 2017 | 30.0 | 0.56 | 7.67 | 2.76 | 1.85% |
| 2018 | 26.8 | 0.26 | 13.69 | 2.98 | 1.55% |
| 2019 | 16.6 | 0.40 | 12.30 | 1.81 | 2.74% |
| 2020 | 22.5 | 0.70 | 14.70 | 2.47 | 2.30% |
| 2021 | 14.9 | 0.25 | 12.11 | 1.61 | 2.60% |
| 2022 | 9.0 | -1.06 | 8.33 | 0.81 | 5.55% |
| 2023 | 7.4 | -0.25 | 3.63 | 0.68 | 9.98% |
| 2024 | 92.1 | -0.94 | 0.92 | 0.32 | 0.37% |
| 2025 | -6.3 | 0.01 | 0.59 | 0.30 | 0.17% |
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2016 | $1.49 | $274.53M | $17.84M | 6.5% |
| 2017 | $2.29 | $301.56M | $27.72M | 9.2% |
| 2018 | $4.62 | $501M | $55.79M | 11.1% |
| 2019 | $6.43 | $713.67M | $77.92M | 10.9% |
| 2020 | $8.68 | $934.84M | $102.86M | 11% |
| 2021 | $13.89 | $1.53B | $164.03M | 10.7% |
| 2022 | $12.73 | $1.6B | $143.57M | 9% |
| 2023 | $9.10 | $1.07B | $99.42M | 9.3% |
| 2024 | $0.19 | $602.46M | $2.09M | 0.3% |
| 2025 | $-1.70 | $385.79M | $-18.67M | -4.8% |
| Year | EPS（平均） | EPS 范围 | 营收（平均） | 营收范围 | 分析师人数 |
|---|---|---|---|---|---|
| 2026 | $-1.98 | $-1.98 – $-1.98 | $273.7M | $273.7M – $273.7M | 1 |
| 2027 | $-2.76 | $-2.76 – $-2.76 | $247.4M | $247.4M – $247.4M | 1 |
